OFAC has added persons to the Specially Designated Nationals and Blocked Persons List, blocking all U.S.-jurisdiction property and prohibiting U.S. persons from transacting with them.
I need the description of this document to create an accurate summary. Please provide the input description along with the title so I can identify the most SMB-relevant facts (deadline, dollar amount, affected industry, or scope).
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
FCC public notice clarifies records requirements for off-the-record communications with agency staff, affecting broadcasters and telecommunications firms subject to FCC jurisdiction.
FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.
I need the description to create the summary. Please provide the description field for "Combined Notice of Filings #1."
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
Proposed Final Judgment in US antitrust case against Live Nation Entertainment requires the company to divest certain assets and comply with operational restrictions affecting ticket sales and venue management; final judgment pending court approval.
Department of the Treasury Bureau of Fiscal Service seeks public comment on the Certificate of Identity information collection under the Paperwork Reduction Act of 1995.
Treasury Department seeks public comment on the TreasuryDirect System information collection under the Paperwork Reduction Act of 1995 to assess respondent burden and paperwork requirements.
FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
